Victory Capital Management »

Silverback Therapeutics shares owned by Victory Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Victory Capital Management from 13F filings

Historical chart of Victory Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Victory Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 199k 10.05
2021-06-30 $895k 29k 30.89
2021-03-31 $1.3M 31k 43.63
2020-12-31 $2.0M 43k 46.34

More positions owned by Victory Capital Management

Qualcomm (QCOM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Eli Lilly & Co. (LLY)
Facebook Inc cl a (META)
Visa (V)
Advanced Micro Devices (AMD)
Truist Financial Corp equities (TFC)
Oracle Corporation (ORCL)
Cisco Systems (CSCO)

View all positions for Victory Capital Management

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics